Market

Stoke Therapeutics stock maintains Buy rating at H.C. Wainwright on positive study data

Stoke Therapeutics stock maintains Buy rating at H.C. Wainwright on positive study data
Read More

Related Posts

Inflation didn’t get any worse before the government shutdown. The Fed is expected to cut rates again.

Inflation didn’t get any worse before the government sh...

US owner of major Russian agriculture firm says no plans to sell up

US owner of major Russian agriculture firm says no plan...

Empire State Realty Trust declares Q4 dividend of $0.035 per share

Empire State Realty Trust declares Q4 dividend of $0.03...

US Treasury Secretary Bessent holds constructive call with China

US Treasury Secretary Bessent holds constructive call w...

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Woodward director Sengstack sells $2.1m in shares

Woodward director Sengstack sells $2.1m in shares